• Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3
    Nov 8 2024

    In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy highlight important indicators for when to suspect hereditary spastic paraplegia, as well as guidelines for testing and interpreting results.

    Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457

    Show more Show less
    2 mins
  • Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2
    Nov 7 2024

    In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss practical approaches to genetic adrenoleukodystrophy.

    Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192

    Show more Show less
    2 mins
  • Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1
    Nov 6 2024

    In the first part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss red flag symptoms that suggest the need for genetic testing in patients with white matter disease.

    Show references:

    https://www.neurology.org/doi/10.1212/NXG.0000000000200192

    https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457

    Show more Show less
    2 mins
  • Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
    Nov 5 2024

    Dr. Rae Bacharach discusses the Neurology Today article, “Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease,” by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com.

    Show reference:

    https://journals.lww.com/neurotodayonline/pages/default.aspx

    https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964

    Show more Show less
    3 mins
  • Interventions for the Acute Management of Migraine Episodes in Adults - Part 3
    Nov 4 2024

    In the final part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss what you need to know about analyzing network meta-analysis.

    Show reference:

    https://www.bmj.com/content/386/bmj-2024-080107

    Show more Show less
    5 mins
  • Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
    Nov 1 2024

    Drs. Justin Abbatemarco, Marius Ringelstein, and Ilya Ayzenberg discuss a new class of complement inhibitors that we're using in NMOSD.

    Show reference:

    https://www.neurology.org/doi/full/10.1212/WNL.0000000000209888

    Show more Show less
    2 mins
  • Interventions for the Acute Management of Migraine Episodes in Adults - Part 2
    Oct 31 2024

    In part two of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss clinical pearls on how to select an acute treatment plan for migraine.

    Show reference:

    https://www.bmj.com/content/386/bmj-2024-080107

    Show more Show less
    5 mins
  • Interventions for the Acute Management of Migraine Episodes in Adults - Part 1
    Oct 30 2024

    In the first part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani explain the significance of this study and how its findings can be applied in clinical practice.

    Show reference:

    https://www.bmj.com/content/386/bmj-2024-080107

    Show more Show less
    5 mins